Measures | Â | Baseline/pre-treatment Mean (SD) | Post-treatment Mean (SD) | 6Â month F-U Mean (SD) | Post-booster Mean (SD) | Effect Size (Cohen's d/ Pearson's r) | ||
---|---|---|---|---|---|---|---|---|
 |  |  |  |  |  | Pre-post-treatment | Post-treatment-6-months Follow-Up | 6 months follow-up- post-booster |
Primary Outcome Measures | ||||||||
Self-Report SDQ | ACC | 2.68 (1.78) | 2.57 (1.69) | 2.94 (2.15) | 2.89 (2.34) | Â | Â | Â |
PROCARE | 3.06 (1.80) | 2.39 (2.08) | 2.41 (1.82) | 1.98 (1.81) | 0.34b2*** | Â | Â | |
PROCARE +  | 2.88 (1.40) | 1.63 (1.46) | 1.92 (1.49) | 1.52 (1.57) | 0.65b3*** |  | 0.34b2** | |
Parent SDQ | ACC | 3.53 (2.43) | 2.53 (2.20) | 2.77 (2.02) | 2.68 (1.92) | 0.49b2*** | Â | Â |
PROCARE | 3.72 (2.37) | 2.44 (1.69) | 2.54 (1.69) | 2.02 (1.56) | 0.49b2*** | Â | 0.36b2*** | |
PROCARE +  | 2.98 (2.01) | 1.52 (1.63) | 1.50 (1.63) | 1.17 (1.42) | 0.61b3*** |  | 0.30b2* | |
CD-RISC | ACC | 25.47 (5.53) | 27.23 (6.55) | 26.19 (5.49) | 26.91 (6.34) | Â | Â | 0.16b1* |
PROCARE | 25.35 (5.32) | 27.37 (6.96) | 28.33 (7.63) | 28.56 (5.76) | 0.29a1*** | Â | Â | |
PROCARE +  | 26.50 (5.50) | 29.31 (6.23) | 29.92 (6.64) | 32.69 (5.76) | 0.48b2*** |  | 0.65a2*** | |
KIDSCREEN | ACC | 36.19 (5.29) | 36.89 (6.01) | 35.53 (6.57) | 36.13 (5.97) | Â | Â | Â |
PROCARE | 35.72 (5.14) | 37.83 (5.78) | 38.11 (5.83) | 38.48 (6.06) | 0.33a1* | Â | Â | |
PROCARE +  | 36.46 (5.30) | 38.38 (5.85) | 38.48 (5.72) | 40.48 (5.66) | 0.37b2** |  | 0.46a1*** | |
Secondary outcome measures | ||||||||
 DERS | ACC | 79.55 (24.73) | 80.96 (24.26) | 77.60 (20.49) | 76.87 (21.36) |  |  |  |
PROCARE | 78.89 (17.91) | 77.07 (21.83) | 72.30 (20.45) | 68.74 (21.55) | Â | Â | 0.27a1* | |
PROCARE +  | 78.33 (20.32) | 71.65 (18.21) | 68.31 (17.48) | 64.50 (18.24) | 0.37a1** |  | 0.35a1** | |
 WAM | ACC | 39.87 (9.10) | 40.64 (12.02) | 41.72 (10.89) | 42.47 (11.82) |  |  |  |
PROCARE | 38.69 (9.35) | 44.13 (11.19) | 45.02 (11.67) | 43.72 (11.38) | 0.67a2*** | Â | Â | |
PROCARE +  | 39.90 (8.33) | 44.23 (9.90) | 42.54 (9.82) | 45.87 (9.63) | 0.38b2** |  | 0.44a1*** | |
 RCADS (Total) | ACC | 19.55 (8.01) | 21.06 (9.05) | 21.55 (11.09) | 21.00 (12.75) |  |  |  |
PROCARE | 22.24 (8.52) | 19.41 (11.02) | 19.67 (11.60) | 16.19 (10.11) | Â | Â | 0.41a1* | |
PROCARE +  | 21.54 (8.94) | 17.50 (10.72) | 17.52 (9.60) | 14.44 (9.76) | 0.45b2*** |  | 0.50a2*** | |
 RCADS (GAD) | ACC | 6.04 (2.59) | 5.72 (2.82) | 6.19 (3.34) | 5.70 (3.70) |  |  |  |
PROCARE | 6.20 (2.62) | 5.67 (3.30) | 5.87 (3.41) | 4.78 (2.65) | Â | Â | 0.38b2*** | |
PROCARE +  | 7.13 (2.51) | 5.88 (3.28) | 5.56 (2.87) | 4.56 (3.11) | 0.37a1** |  | 0.42a1*** | |
 RCADS (SoP) | ACC | 4.66 (2.72) | 5.00 (3.21) | 5.13 (3.70) | 5.17 (3.38) |  |  |  |
PROCARE | 6.02 (3.49) | 4.96 (3.31) | 5.17 (3.25) | 4.43 (2.99) | Â | Â | Â | |
PROCARE +  | 5.27 (3.16) | 3.96 (2.93) | 4.23 (2.88) | 3.38 (2.75) | 0.39b2** |  | 0.41b2*** | |
 RCADS (PD) | ACC | 1.34 (1.61) | 1.89 (2.00) | 1.85 (2.12) | 1.91 (2.77) |  |  |  |
PROCARE | 1.26 (1.26) | 1.48 (1.79) | 1.44 (1.88) | 1.02 (2.00) | Â | Â | 0.29b1* | |
PROCARE +  | 1.38 (1.62) | 1.23 (2.11) | 1.06 (1.42) | 0.63 (0.97) |  |  | 0.36b2** | |
 RCADS (MDD) | ACC | 3.45 (2.19) | 4.09 (2.38) | 3.87 (2.79) | 3.96 (2.57) | 0.31b2* |  |  |
PROCARE | 3.98 (2.12) | 3.09 (2.27) | 3.26 (2.47) | 2.91 (2.17) | 0.39b3** | Â | Â | |
PROCARE +  | 3.15 (1.93) | 2.62 (2.13) | 2.75 (2.09) | 2.46 (2.14) |  |  |  | |
 RCADS (SAD) | ACC | 1.32 (1.73) | 1.26 (1.78) | 1.28 (2.02) | 1.36 (2.24) |  |  |  |
PROCARE | 1.57 (1.81) | 1.35 (1.46) | 1.11 (1.76) | 0.83 (1.54) | Â | Â | 0.28b1* | |
PROCARE +  | 1.56 (2.52) | 0.77 (1.28) | 0.96 (1.66) | 0.65 (1.40) | 0.44b2*** |  |  | |
 RCADS (OCD) | ACC | 2.74 (1.92) | 3.36 (2.27) | 3.19 (2.24) | 2.89 (2.40) |  |  |  |
PROCARE | 3.20 (2.40) | 2.93 (2.24) | 2.70 (2.21) | 2.17 (2.06) | Â | Â | 0.35b1** | |
PROCARE +  | 3.04 (2.32) | 3.00 (2.67) | 2.50 (2.37) | 2.08 (2.19) |  |  | 0.30b2* |